Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer’s…
Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia.
He said the treatment is effective but doesn't carry the serious side effects of other traditional medications. The Food and Drug administration approved Cobenfy in September of 2024, and it is the first new type of treatment for the disorder in decades.CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia, saying the treatment is effective without the serious side effects of other traditional medications.
"Unfortunately, until Cobenfy, we did not have a fundamentally new mechanism of action to treat those patients, and now we do," Boerner said."We get efficacy on par with the best of the existing atypicals, but we don't see the side effect profile that you see with those drugs."Schizophrenia is a debilitating mental illness that can cause hallucinations, delusions, paranoia and other emotional and behavioral issues.
Boerner also addressed concerns about upcoming patent expirations the company currently faces, which would likely lead to revenue losses. He said Bristol Myers has a"young portfolio growing assets," as well as"a string of new catalysts that are going to have data coming out over the next 18 to 24 months." He also said the company is in a strong financial position that allows it to continue to provide shareholders with"an attractive dividend.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Peak Design CEO denies rumors backpack company helped ID suspect in UnitedHealthcare CEO shootingThe CEO of a company that makes high-end backpacks said he and his employees have received threats after reports he contacted a police tip line when he spotted one of the company's bags in the surveillance video of the shooting of UnitedHealthcare CEO Brian Thompson.
Read more »
Peak Design CEO denies rumors backpack company helped ID suspect in UnitedHealthcare CEO shootingThe CEO of a company that makes high-end backpacks said he and his employees have received threats after reports he contacted a police tip line when he spotted one of the company's bags in the surveillance video of the shooting of UnitedHealthcare CEO Brian Thompson.
Read more »
Peak Design CEO denies rumors backpack company helped ID suspect in UnitedHealthcare CEO shootingThe CEO of a company that makes high-end backpacks said he and his employees have received threats after reports he contacted a police tip line when he spotted one of the company's bags in the surveillance video of the shooting of UnitedHealthcare CEO Brian Thompson.
Read more »
Peak Design CEO denies rumors backpack company helped ID suspect in UnitedHealthcare CEO shootingThe CEO of a company that makes high-end backpacks said he and his employees have received threats after reports he contacted a police tip line when he spotted one of the company's bags in the surveillance video of the shooting of UnitedHealthcare CEO Brian Thompson.
Read more »
Quantum Computing CEO Calls Nvidia CEO 'Dead Wrong' After Market DropFollowing Nvidia CEO Jensen Huang's statement that quantum computers are decades away, D-Wave Quantum CEO Alan Baratz refuted Huang's claims and highlighted his company's current commercial success in the quantum computing field.
Read more »
Alpha Announces CEO Retirement and Appointment of Interim CEOAlpha Corp announces the retirement of its President and CEO, Michael Hopley, effective December 31, 2024. Hopley will remain as a director and Chairman of the Board. Timothy Livesey, a current director, has been appointed as Interim CEO. Livesey brings over 35 years of experience in exploration and development.
Read more »